US3200815A - Coil spring intra-uterine contraceptive device and method of using - Google Patents
Coil spring intra-uterine contraceptive device and method of using Download PDFInfo
- Publication number
- US3200815A US3200815A US191674A US19167462A US3200815A US 3200815 A US3200815 A US 3200815A US 191674 A US191674 A US 191674A US 19167462 A US19167462 A US 19167462A US 3200815 A US3200815 A US 3200815A
- Authority
- US
- United States
- Prior art keywords
- coil
- cannula
- strand
- uterine
- uterus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003433 contraceptive agent Substances 0.000 title claims description 20
- 230000002254 contraceptive effect Effects 0.000 title claims description 20
- 238000000034 method Methods 0.000 title description 23
- 210000004291 uterus Anatomy 0.000 description 30
- 238000003780 insertion Methods 0.000 description 14
- 230000037431 insertion Effects 0.000 description 14
- 239000011324 bead Substances 0.000 description 11
- 230000035935 pregnancy Effects 0.000 description 10
- 210000003679 cervix uteri Anatomy 0.000 description 8
- 230000010339 dilation Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 210000001215 vagina Anatomy 0.000 description 6
- 241000255789 Bombyx mori Species 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 241001631457 Cannula Species 0.000 description 2
- 238000001949 anaesthesia Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000543381 Cliftonia monophylla Species 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/142—Wirelike structures, e.g. loops, rings, spirals
Definitions
- This invention relates to new and useful improvements in intra-uterine birth control devices and more particularly relates to a painless method and object that ma be introduced through the cervix although having a diameter in situ considerably larger than the normal cervical canal with the presence and relative position of the object within the uterus being readily and easily determinable at all times.
- a report (10 Yokohama Medical Bulletin 89-105 1959) on the Ota device describes almost 20,00 cases having a frequency of conception of about 2.2% in two years. The rate of conception of a portion of the cases were deter mined by the StiX-Notestein method and showed 96.5% effectiveness, this being equivalent to one pregnancy in 40 years of exposure.
- a silkworm gut ring had also been developed which is preferred by some writers because of the insertion dlfiiculty of the Graefenberg ring. As described by Oppenheimer, this is a ring formed of three or four intertwined threads of silkworm gut, each about 14 cm. long with a knot at each end. These threads and the resultant ring are very stiff and must be dipped into hot water to avoid cracking of the threads and permit knotting of the ends so that the end points or cracked threads will not pierce the uterine wall. Furthermore, this ring must be formed just before use, as otherwise it will lose its elasticity properties which are essential. A report (78 Am. J. Obst. & Gynec.
- Diaphragms although having certain psychological disadvantages and being inconvenient, are generally considered the most effective method in general use in the United States.
- Halton also coiled silkworm gut in individual pieces and placed two or three in the uterus via capsules but they caused considerable uterine disturbances.
- the intra-uterine rings already meet several of the criteria for an ideal contraceptive as they are (l) by far the most effective, (2) cheap to manufacture, (3) permanently applicable but subject to removal at any time, (4) offer no physical or psychological interference with intercourse, and (5) safe to use.
- the plastic or metal rings are either very painful to insert and remove or must be transferred with anaesthesia and the silkworm gut ring must be formed immediately before insertion and must be critically treated with hot water to avoid cracking and subsequent piercing of the uterine wall, all of which are time consuming and detract from the universal acceptance of intra-uterine rings, particularly on a mass basis as is desired in certain over-populated areas of the world.
- an ideal intra-uterine device may be provided by taking an elongated bombn'ble element with two free ends having a transverse diameter or largest dimension not greater than about 4 mm. but which is coiled, curved or otherwise formed to define a substantial area in one plane.
- the device is flexible enough so that it can be straightened to a strand by slight force but is rigid enough to immediately return to its original shape when the force is removed, i.e., it exhibits perfect elasticity. This permits the painless insertion of the device through the cervical canal through a cannula into the uterus where it will immediately regain its original shape on being pushed out of the cannula.
- the device may be provided with an integral follower which will extend through the cervical canal and into the vagina for a short distance where it may be sensed with the fingers through the vagina, the position determined and the entire unit easily removed if desired.
- FIG. 1 is a frontal section through the uterus showing an intra-uterine coil being placed in the uterine cavity;
- FIG. 2 is a section through line 2-2 of FIG. 1;
- FIG. 3 is a sagittal section through the uterus after placement of the coil of FIG. 1;
- FIG. 4 is a perspective view of the coil of FIGS. 1 to 3;
- FIGS. 5 to 8 are perspective views of modified intrauterine devices in accordance with this invention.
- FIG. 9 is a perspective view of a coil with a sensing follower
- FIG. 10 is a frontal section through the uterus showing the coil of FIG. 9 being placed.
- FIG. 11 is a sagittal section through the uteru after placement of the coil of FIG. 9.
- This invention as illustrated in the drawings shows several alternative modified forms or shapes and the placement of such coils in the uterus, although in every form the contraceptive has two free ends which may be pulled apart to form an elongated strand.
- FIGS. 4 to 9 all have two free ends, are made of flexible material and thus may be lengthened into a straight strand by application of slight force.
- many other shape can be made having the same properties, it being within the scope of this invention to have a shape which is deformable to an elongated straight strand but when free returns to define a shape in substantially one plane and of substantial area relative to the cross-section of the strand and preferably in which the total curvature is more than 360, the curvature being all in one direction as in coils 13 and 25, FIGS. 4 and 9, in two directions as in FIGS. 5, 6 and 7 or in several directions as in FIG. 8.
- These coils may be formed of any inert material which exhibits the proper elasticity to reform the coil from a straight strand and is sufiiciently inert to be considered safe for intra-uterine application. It is preferred to use plastics that have been tested and found inert to the human body such as polyethylene, polypropylene, polyethylene glycol terephthalate (Dacron), polytetrafluoroethylene (Teflon), polyvinyls, silicones, etc. Metals coated with plastics or otherwise inert may also be used. I prefer to use polyethylene and have found an excellent formulation to be 80% polyethylene and 20% barium sulfate which are mixed as powders and then molded into any of the various shapes by injection molding under pressure.
- the barium sulfate is desirable, but not necessary, so that the position and presence of the coil may be noted at any time by radiology.
- Other radio opaque materials can, of course, be used.
- the coil of FIG. 9 will seldom, if ever, require radiology, and thus is less concerned with a radio opaque material.
- the placement of the Graefenberg ring and other devices have created a diflicult problem in the past.
- the uterine cavity is largely a potential cavity but does not exist as an actual cavity until and unless there is something within the uterus. Therefore, to avoid irritation and other inconveniences, it is essential that the primary plane of the coil lie within the frontal plane of the uterus as is shown in FIGS. 1, 3, l and 11. Thus, the placement of the coil assumes importance.
- This flange which is approximately 2 inches from the end of the cannula, is not necessary, of course, but serves as a convenient measurement to insure that the end of the cannula has passed sufliciently high into the uterine cavity 18 to permit discharge of the coil and also to indicate the plane of the coil to the operator.
- the cannula if metal, will generally be slightly curved in the sagittal plane for ease and convenience of insertion and if made of plastic will also be slightly forced into this position by the tendency of the coil to return to its curved shape and by the natural curve of the uteru and cervix. In any event, the coil will be ready to curve itself on release in the same plane as the curvature of the cannula and since it is highly desirable that the coil lie in the frontal plane, the cannula should be rotated 90 and then the plunger 12 placed in position (if not before) and pushed to force out the coil 13 which will then take the position shown in FIGS. 1 and 3.
- inner end 15 of the coil enter the cavity first (and outer end 20 last) because the free inner end makes little movement, whereas if outer end 20 enters first, there is relatively extensive movement of free end 20 which may ru'b against the cavity wall.
- Outer oval flange 19 is preferably provided near the exterior end of the cannula to also aid the operator to determine the plane of the cannula at any time, but the inner flange 17 is far more important for this purpose. If the flanges were circular, they could be marked to indicate the cannula plane but the oval shape is convenient for both visual and tactile sensing.
- the cannula and coil have an oval (or rounded rectangular) cross-section (see FIG. 2) rather than a circular one as the latter would permit rotation of the coil within the cannula and the operator would not know in which plane he was plae ing the coil.
- FIG. 2 the long dimension shown in FIG. 2 is in the frontal plane on the original insertion of the cannula the operator by a mere rotation, which will be obvious from observing flange 17 or 19, will be in a position to discharge the coil into the frontal plane in the manner shown in FIGS. 1 and 3.
- the oval cross-section helps retain the curvature in the plane transverse to the shorter dimension. 1
- FIGS. 9, l0 and lil The preferred embodiment of the invention is shown in FIGS. 9, l0 and lil, coil 25 being similar to coil 13 of FIG. 4, except that the leading end 26 of coil 25 is of a slightly reduced diameter and the trailing end has attached thereto follower 27 which has a plurality of enlarged areas or heads 29 spaced along its trailing end Zone 28.
- the reduced diameter of leading end 26 aids the unit to start curling immediately on its release from the cannula.
- cannula 30 is longer and plunger 31 about the same length as the corresponding elements 11 and .12 in FIG. 1.
- the longer cannula 30 is required to house the additional length of follower 27 therein.
- the leading end of cannula 30 is placed similar to 11 and the plunger 31 pushed to its limit as shown, at which point coil 25 is within the uterine cavity 18 but the follower 27 remains in the cannula.
- the cannula is then removed and follower 27 and beads 29 (both of less diameter than the trailing portion of coil 25) assume the position in the cervical canal with the beads extending partly out into the vagina.
- the extra beads are severed to leave the placement :of the unit as shown in FIG. 11.
- the coil portion occupies the same position as coil 13 in FIG. 3 but the follower 27 extends through the cervical canal of the uterus with the beads or thickened areas 29 being positioned near the opening of the cervix.
- the coil of FIG. 9 has an elongated zone 28 of spaced beads 29 but after positioning of the coil in the uterus, the extra length of beads may be severed so that only one or two heads are extending into the vagina, the follower being pliable and harmless to any object found in the vagina.
- This follower serves three functions, the first and more important being that the presence and relative position of the coil within the uterus may readily be determined with the fingers by merely feeling for and counting the beads. This is important because the primary fault of coil 13 has been its passage from the uterus on a few occasions without the knowledge of the patient.
- the second important reason is the fact that the entire coil can be readily removed by merely grasping beads 29 and pulling the coil from the uterus by hand and thus avoiding the insertion of a hooked device into the uterus as is required with coil 13.
- a further advantage of the follower is the fact that the unthickened portion of the follower is not round but,
- Atlhough coil 13 of FIG. 4 and the other coils of FIGS. 5 through 8 have been found to give excellent results as a contraceptive as long as they remain in position, they may be lost without the knowledge of the patient, are more difficult to remove than coil 25 and cannot be observed in position without radiology and accordingly coil 25 is to be preferred.
- the larger size coils are preferred as they reduce both the ejections and pregnancies, there having been no pregnancies with the 33 mm. coils. Ejection may lead readily to pregnancies when the woman is unaware of the ejection and is falsely relying on its presence.
- the coils longest transverse dimension should not be more than 4 mm. and I have found, in fact, that a preferred dimension is about 2 by 3 mm. and 16 cm. long, the follower of FIG. 9 being an additional 10 cm., including the distal 5 cm. having beads 29.
- the preferred diameter, i.e. largest dimension, across the coil per se is about 3.3 cm., the range being 2 to 4 cm.
- the smaller sizes are, of course, ejected more but some women with a small uterus cannot receive a 3.3 cm. coil so that a 2.5 cm. coil is generally provided for them.
- coils 13 and 25 of FIGS. 4 and 9 are very adept at being positioned in the frontal plane, inasmuch as the direction of curvature never changes while the coil is being discharged.
- the other patterns shown do change direction of curvature which means rotation of the entire unit discharged prior to the change.
- these patterns are more apt to become caught in the uterine walls on discharge from the cannula Without taking up the desirable frontal plane and this may thereafter cause irritation for the patient.
- the simple coils 13 and 25 have been found highly satisfactory for easy insertion into the uterus.
- the coil of FIG. 6 is provided with thickened areas which aid the elastic properties of the coil. All of the coils are preferably provided with thick ends (15 and on FIG. 4) to prevent piercing or irritation of the uterine wall.
- FIGS. 4 to 9 have shown no side effects, except for slight cramps and spot-ting in a few women for a few days after insertion and occasionally some preand post-menstrual staining for a few months.
- the preferred time for insertion is the end of the second week of the menstrual cycle, i.e., around ovulation time and not sooner than two cycles after a delivery or abortion.
- FIGS. 4 to 8 are easily and painlessly removed by inserting a hook through the cervix, securing the coil and pulling it back through the cervix, whereas the coil of FIG. 9 is merely pulled out.
- the coils can be left in the uterus for several years and should be removed only if there is a disturbance in the uterus, after menopause, or a decision to resume exposure to pregnancy.
- FIGS. 4 to 9 When the word coil is used in the specification or claims, it is intended to cover any device such as shown in FIGS. 4 to 9 which are formed from a strand having two free ends but is curved more or less continually in one or more directions.
- An infra-uterine contraceptive comprising an elongated strand having two free ends and a free shape in substantially one plane that includes a coil adapted to lie within the uterine cavity connected to a substantially straight follower adapted to extend through the cervical canal, said strand being readily deformable to a straight line by application of force and always returning to said coil shape when free of said force, said strand in its free shape or deformed to a straight line presenting a continuous smooth surface along its longitudinal extent.
- a method of preventing pregnancy comprising placing an elongated strand within a cannula passable through the cervical canal without dilation, said strand having two free ends and a free shape as a coil in substantially one plane, said strand being readily deformable to a straight line by application of force and always returrnng to said coil shape when free of said force, said coil and said strand presenting a continuous smooth surface along their longitudinal extents, inserting one end of said cannula through said cervical canal and into the uterine cavity, forcing said strand with a plunger through said cannula into said uterine cavity without contact between said strand and said cervical canal, whereby said strand regains said free coil shape within said uterine cavity.
- said elongated strand in free shape includes said coil and a substantially straight follower and said follower is positioned to extend through said cervical canal with its free end in the vagina.
- a method of preventing pregnancy comprising insertion within a uterine cavity of a contraceptive comprising an elongated straight strand having tWo free ends and a free shape as a coil in substantially one plane, said strand being readily deformable to a straight line by application of force and always returning to said coil shape when free of said force, said coil and said strand presenting a continuous smooth surface along their longitudinal extents.
- a method of preventing pregnancy comprising insertion within a uterine cavity of a contraceptive comprising an elongated straight strand having two free ends and a free shape as a coil in substantially one plane adapted to lie within the uterine cavity and a substantially straight follower adapted to extend through the cervical canal, said strand being readily deformable to a straight References Cited by the Examiner UNITED STATES PATENTS 662,716 11/00 Gaedke 128-130X 946,993 1/10 Bolton 58-114 1,881,997 10/32 Browne 267 1 1,896,071 2/33 Clark 128-430 2,085,368 6/37 Kendall 128341 OTHER REFERENCES Product Engineering: Spring Material Substitutes, February 1943, pp. 112113.
Landscapes
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Description
1965 V MARGULIES 3,200,815
COIL SPRING INTRAUTERINE CONTRACEPTIVE DEVICE AND METHOD OF USING Filed April 24, 1962 2 Sheets-Sheet 1 FIG. 1 FIG. 3
' FIG. 5
IN VEN TOR. LAZAR MAR GU LIE 5 BY GwiMLM ATTORNEYS Aug. 17, 1965 1.. MARGULIES 3,200,815
COIL SPRING INTRAUTERINE CONTRACEPTIVE DEVICE AND METHOD OF USING Filed April 24, 1962 2 Sheets-Sheet 2 BYM Mq M United States Patent 3,266,315 COIL SPRING lNTRA-UTERINE tZUNTRACElP- TlVE DEVICE AND METHQD 0F USING Lazar Margulies, New York, N.Y., assignor to Mount Sinai Hospital Research Foundation, Inc, New York,
N.Y., a corporation of New York Filed Apr. 24, 1962, Ser. No. 191,674- 23 Galina (Cl. 123-139) This invention relates to new and useful improvements in intra-uterine birth control devices and more particularly relates to a painless method and object that ma be introduced through the cervix although having a diameter in situ considerably larger than the normal cervical canal with the presence and relative position of the object within the uterus being readily and easily determinable at all times.
Birth control or contraception has been practiced by innumerable methods to various degrees of effectiveness for centuries and in modern times has become the sub ject of organized study and even actively encouraged by certain governments in the world. However, no fully satisfactory method of preventing pregnancy has been developed, it being desirable that a method be effective, safe, cheap, simple, physically and psychologically acceptable and permanently applicable without repeated regimen but subject to cancellation at will.
In 1929 Graefenberg reported on the celebrated ring which bears his name and which became the subject of dispute among gynecologists all over the world. This ring was about one inch in diameter, flexible and formed of silver originally and subsequently of other metals that are presumably inert. It required dilation of the cervix to about mm. to permit passage of the ring when folded which was extremely painful unless anaesthesia were utilized. Ota in Japan added a central element to the ring and formed it of gold, gilt silver or polyethylene with a nylon coil around the outer circle, to overcome certain objections that had been raised but the dilation of the cervical canal remained a disadvantage as before. A report (10 Yokohama Medical Bulletin 89-105 1959) on the Ota device describes almost 20,00 cases having a frequency of conception of about 2.2% in two years. The rate of conception of a portion of the cases were deter mined by the StiX-Notestein method and showed 96.5% effectiveness, this being equivalent to one pregnancy in 40 years of exposure.
A silkworm gut ring had also been developed which is preferred by some writers because of the insertion dlfiiculty of the Graefenberg ring. As described by Oppenheimer, this is a ring formed of three or four intertwined threads of silkworm gut, each about 14 cm. long with a knot at each end. These threads and the resultant ring are very stiff and must be dipped into hot water to avoid cracking of the threads and permit knotting of the ends so that the end points or cracked threads will not pierce the uterine wall. Furthermore, this ring must be formed just before use, as otherwise it will lose its elasticity properties which are essential. A report (78 Am. J. Obst. & Gynec. 446-454 1959) primarily on the silkworm gut ring describes over 1,000 insertions (a few were the Graefenberg silver ring) on 329 patients with an effective ness of about one pregnancy in 4-6 years of exposure. This report points out that rings are 25 times as effective as rubber caps (diaphragms). Diaphragms, although having certain psychological disadvantages and being inconvenient, are generally considered the most effective method in general use in the United States.
Halton also coiled silkworm gut in individual pieces and placed two or three in the uterus via capsules but they caused considerable uterine disturbances.
ice
The Graefenberg rings were involved in heated controversy when first reported which apparently precluded any substantial use of the devices at that time. However, the two aforementioned reports, based on over 20,000 cases, show the devices to be eifective and safe, and particularly when inert materials are used.
Thus the intra-uterine rings already meet several of the criteria for an ideal contraceptive as they are (l) by far the most effective, (2) cheap to manufacture, (3) permanently applicable but subject to removal at any time, (4) offer no physical or psychological interference with intercourse, and (5) safe to use. However, the plastic or metal rings are either very painful to insert and remove or must be transferred with anaesthesia and the silkworm gut ring must be formed immediately before insertion and must be critically treated with hot water to avoid cracking and subsequent piercing of the uterine wall, all of which are time consuming and detract from the universal acceptance of intra-uterine rings, particularly on a mass basis as is desired in certain over-populated areas of the world.
Therefore, it is an object of this invention toprovide an ideal intra-uterine device for contraceptive purposes.
It is also an object of this invention to provide an intrauterine coil that may be cheaply fabricated in mass quan tities prior to the time for inserting same.
It is an additional object of this invention to provide such an intra-uterine coil (and method) that may be painlessly and simply inserted and removed through the normal cervical canal without dilation.
It is a further object of this invention to provide an intra-uterine coil and method of placing same that permits placement within the frontal plane of the uterus to avoid any discomfort from the device.
It is another object of this invention to provide such an intra-uterine coil, the presence and relative position of which can be easily and immediately determined by the particular subject or the doctor.
I have found that an ideal intra-uterine device may be provided by taking an elongated fiern'ble element with two free ends having a transverse diameter or largest dimension not greater than about 4 mm. but which is coiled, curved or otherwise formed to define a substantial area in one plane. The device is flexible enough so that it can be straightened to a strand by slight force but is rigid enough to immediately return to its original shape when the force is removed, i.e., it exhibits perfect elasticity. This permits the painless insertion of the device through the cervical canal through a cannula into the uterus where it will immediately regain its original shape on being pushed out of the cannula. The device may be provided with an integral follower which will extend through the cervical canal and into the vagina for a short distance where it may be sensed with the fingers through the vagina, the position determined and the entire unit easily removed if desired.
With the above objects and features in View, the nature of which will be more apparent, the invention will be more fully understood by reference to the drawings, the accompanying detailed description and the appended claims.
In the drawings:
FIG. 1 is a frontal section through the uterus showing an intra-uterine coil being placed in the uterine cavity;
FIG. 2 is a section through line 2-2 of FIG. 1;
FIG. 3 is a sagittal section through the uterus after placement of the coil of FIG. 1;
FIG. 4 is a perspective view of the coil of FIGS. 1 to 3;
FIGS. 5 to 8 are perspective views of modified intrauterine devices in accordance with this invention;
FIG. 9 is a perspective view of a coil with a sensing follower;
FIG. 10 is a frontal section through the uterus showing the coil of FIG. 9 being placed; and
FIG. 11 is a sagittal section through the uteru after placement of the coil of FIG. 9.
This invention as illustrated in the drawings shows several alternative modified forms or shapes and the placement of such coils in the uterus, although in every form the contraceptive has two free ends which may be pulled apart to form an elongated strand.
The various coils shown in FIGS. 4 to 9 all have two free ends, are made of flexible material and thus may be lengthened into a straight strand by application of slight force. Moreover, many other shape can be made having the same properties, it being within the scope of this invention to have a shape which is deformable to an elongated straight strand but when free returns to define a shape in substantially one plane and of substantial area relative to the cross-section of the strand and preferably in which the total curvature is more than 360, the curvature being all in one direction as in coils 13 and 25, FIGS. 4 and 9, in two directions as in FIGS. 5, 6 and 7 or in several directions as in FIG. 8.
These coils may be formed of any inert material which exhibits the proper elasticity to reform the coil from a straight strand and is sufiiciently inert to be considered safe for intra-uterine application. It is preferred to use plastics that have been tested and found inert to the human body such as polyethylene, polypropylene, polyethylene glycol terephthalate (Dacron), polytetrafluoroethylene (Teflon), polyvinyls, silicones, etc. Metals coated with plastics or otherwise inert may also be used. I prefer to use polyethylene and have found an excellent formulation to be 80% polyethylene and 20% barium sulfate which are mixed as powders and then molded into any of the various shapes by injection molding under pressure.
The barium sulfate is desirable, but not necessary, so that the position and presence of the coil may be noted at any time by radiology. Other radio opaque materials can, of course, be used. The coil of FIG. 9 will seldom, if ever, require radiology, and thus is less concerned with a radio opaque material.
As pointed out before, the placement of the Graefenberg ring and other devices have created a diflicult problem in the past. As will be appreciated from FIGS. 3 and 11, the uterine cavity is largely a potential cavity but does not exist as an actual cavity until and unless there is something within the uterus. Therefore, to avoid irritation and other inconveniences, it is essential that the primary plane of the coil lie within the frontal plane of the uterus as is shown in FIGS. 1, 3, l and 11. Thus, the placement of the coil assumes importance.
The placement of these coils is accomplished through a cannula 11 provided with an internal plunger 12, such cannulas generally having a diameter of less than 4.5 mm. if they are to be inserted painlessly through the cervical canal without dilation. Any of the coils of FIGS. 4 to 8 (FIG. 4 as shown) are inserted into the cannula 11, and the end of the cannula then passed through the cervix 14 of the uterus 16 until the inner oval flange 17 contacts the cervix. This flange which is approximately 2 inches from the end of the cannula, is not necessary, of course, but serves as a convenient measurement to insure that the end of the cannula has passed sufliciently high into the uterine cavity 18 to permit discharge of the coil and also to indicate the plane of the coil to the operator.
The cannula, if metal, will generally be slightly curved in the sagittal plane for ease and convenience of insertion and if made of plastic will also be slightly forced into this position by the tendency of the coil to return to its curved shape and by the natural curve of the uteru and cervix. In any event, the coil will be ready to curve itself on release in the same plane as the curvature of the cannula and since it is highly desirable that the coil lie in the frontal plane, the cannula should be rotated 90 and then the plunger 12 placed in position (if not before) and pushed to force out the coil 13 which will then take the position shown in FIGS. 1 and 3. It is also preferred that inner end 15 of the coil enter the cavity first (and outer end 20 last) because the free inner end makes little movement, whereas if outer end 20 enters first, there is relatively extensive movement of free end 20 which may ru'b against the cavity wall. Outer oval flange 19 is preferably provided near the exterior end of the cannula to also aid the operator to determine the plane of the cannula at any time, but the inner flange 17 is far more important for this purpose. If the flanges were circular, they could be marked to indicate the cannula plane but the oval shape is convenient for both visual and tactile sensing.
For convenience in placement of the coil in a specific plane, it has been found desirable that the cannula and coil have an oval (or rounded rectangular) cross-section (see FIG. 2) rather than a circular one as the latter would permit rotation of the coil within the cannula and the operator would not know in which plane he was plae ing the coil. Thus if the long dimension shown in FIG. 2 is in the frontal plane on the original insertion of the cannula the operator by a mere rotation, which will be obvious from observing flange 17 or 19, will be in a position to discharge the coil into the frontal plane in the manner shown in FIGS. 1 and 3. In addition, the oval cross-section helps retain the curvature in the plane transverse to the shorter dimension. 1
The preferred embodiment of the invention is shown in FIGS. 9, l0 and lil, coil 25 being similar to coil 13 of FIG. 4, except that the leading end 26 of coil 25 is of a slightly reduced diameter and the trailing end has attached thereto follower 27 which has a plurality of enlarged areas or heads 29 spaced along its trailing end Zone 28. The reduced diameter of leading end 26 aids the unit to start curling immediately on its release from the cannula.
As shown in FIG. 10, cannula 30 is longer and plunger 31 about the same length as the corresponding elements 11 and .12 in FIG. 1. The longer cannula 30 is required to house the additional length of follower 27 therein. The leading end of cannula 30 is placed similar to 11 and the plunger 31 pushed to its limit as shown, at which point coil 25 is within the uterine cavity 18 but the follower 27 remains in the cannula. The cannula is then removed and follower 27 and beads 29 (both of less diameter than the trailing portion of coil 25) assume the position in the cervical canal with the beads extending partly out into the vagina. The extra beads are severed to leave the placement :of the unit as shown in FIG. 11.
As shown in FIG. 11, when coil 25 is in position in the uterus, the coil portion occupies the same position as coil 13 in FIG. 3 but the follower 27 extends through the cervical canal of the uterus with the beads or thickened areas 29 being positioned near the opening of the cervix. In fact, since the cervical canal is of variable length in different patients, the coil of FIG. 9 has an elongated zone 28 of spaced beads 29 but after positioning of the coil in the uterus, the extra length of beads may be severed so that only one or two heads are extending into the vagina, the follower being pliable and harmless to any object found in the vagina.
This follower serves three functions, the first and more important being that the presence and relative position of the coil within the uterus may readily be determined with the fingers by merely feeling for and counting the beads. This is important because the primary fault of coil 13 has been its passage from the uterus on a few occasions without the knowledge of the patient.
The second important reason is the fact that the entire coil can be readily removed by merely grasping beads 29 and pulling the coil from the uterus by hand and thus avoiding the insertion of a hooked device into the uterus as is required with coil 13.
A further advantage of the follower is the fact that the unthickened portion of the follower is not round but,
is oval lOI' flat-shaped and thus by feeling the follower the doctor will immediately know whether the coil 25 is laying in the proper plane as shown in FIG. 11 or whether it may be lying at an angle to that plane which would tend to irritate the uterine walls.
The following data has been accumulated on different sizes and modifications of the coils:
Thus the larger size coils are preferred as they reduce both the ejections and pregnancies, there having been no pregnancies with the 33 mm. coils. Ejection may lead readily to pregnancies when the woman is unaware of the ejection and is falsely relying on its presence.
In view of the fact that the largest cannulas for cervical insertion without dilation are not more than 4.5 mm. in their longest transverse dimension, the coils longest transverse dimension should not be more than 4 mm. and I have found, in fact, that a preferred dimension is about 2 by 3 mm. and 16 cm. long, the follower of FIG. 9 being an additional 10 cm., including the distal 5 cm. having beads 29. The preferred diameter, i.e. largest dimension, across the coil per se is about 3.3 cm., the range being 2 to 4 cm. The smaller sizes are, of course, ejected more but some women with a small uterus cannot receive a 3.3 cm. coil so that a 2.5 cm. coil is generally provided for them.
One of the advantages of coils 13 and 25 of FIGS. 4 and 9 is the fact that they are very adept at being positioned in the frontal plane, inasmuch as the direction of curvature never changes while the coil is being discharged. However, .the other patterns shown do change direction of curvature which means rotation of the entire unit discharged prior to the change. Thus these patterns are more apt to become caught in the uterine walls on discharge from the cannula Without taking up the desirable frontal plane and this may thereafter cause irritation for the patient. Thus the simple coils 13 and 25 have been found highly satisfactory for easy insertion into the uterus.
As will be noted, the coil of FIG. 6 is provided with thickened areas which aid the elastic properties of the coil. All of the coils are preferably provided with thick ends (15 and on FIG. 4) to prevent piercing or irritation of the uterine wall.
These various designs shown in FIGS. 4 to 9 have shown no side effects, except for slight cramps and spot-ting in a few women for a few days after insertion and occasionally some preand post-menstrual staining for a few months. The preferred time for insertion is the end of the second week of the menstrual cycle, i.e., around ovulation time and not sooner than two cycles after a delivery or abortion.
The coils of FIGS. 4 to 8 are easily and painlessly removed by inserting a hook through the cervix, securing the coil and pulling it back through the cervix, whereas the coil of FIG. 9 is merely pulled out. The coils can be left in the uterus for several years and should be removed only if there is a disturbance in the uterus, after menopause, or a decision to resume exposure to pregnancy.
When the word coil is used in the specification or claims, it is intended to cover any device such as shown in FIGS. 4 to 9 which are formed from a strand having two free ends but is curved more or less continually in one or more directions.
I claim:
1. An infra-uterine contraceptive comprising an elongated strand having two free ends and a free shape in substantially one plane that includes a coil adapted to lie within the uterine cavity connected to a substantially straight follower adapted to extend through the cervical canal, said strand being readily deformable to a straight line by application of force and always returning to said coil shape when free of said force, said strand in its free shape or deformed to a straight line presenting a continuous smooth surface along its longitudinal extent.
2. The contraceptive of claim 1 wherein the curvature of said coil exceeds 360.
3. The contraceptive of claim 1 wherein said strand is made of molded plastic.
4. The contraceptive of claim 1 wherein said strand is made of molded polyethylene.
5. The contraceptive of claim 1 wherein said coil is curved in one direction only.
6. The contraceptive of claim 1 wherein said coil is curved in one direction only for at least about 720.
7. The contraceptive of claim 1 wherein the transverse section of said coil has one dimension greater than the other.
8. The contraceptive of claim 1 wherein the free end of said follower includes spaced beads.
9. The contraceptive of claim 1 wherein the transverse section of said follower has one dimension greater than the other.
It). A method of preventing pregnancy comprising placing an elongated strand within a cannula passable through the cervical canal without dilation, said strand having two free ends and a free shape as a coil in substantially one plane, said strand being readily deformable to a straight line by application of force and always returrnng to said coil shape when free of said force, said coil and said strand presenting a continuous smooth surface along their longitudinal extents, inserting one end of said cannula through said cervical canal and into the uterine cavity, forcing said strand with a plunger through said cannula into said uterine cavity without contact between said strand and said cervical canal, whereby said strand regains said free coil shape within said uterine cavity.
11. The method of claim It) wherein said cannula and said strand are positioned relative to said uterus so that said strand emerges from said cannula and regains said free coil shape with said coil plane being in the frontal plane of said uterus.
12. The method of claim 10 wherein said elongated strand in free shape includes said coil and a substantially straight follower and said follower is positioned to extend through said cervical canal with its free end in the vagina.
13. The method of claim 12 wherein said free end of said follower is provided with spaced sensing beads.
14. The method of claim 12 wherein the transverse section of said follower has one dimension greater than the other.
15. The method of claim 11 wherein said coil is curved in one direction only.
16. The method of claim 15 wherein the inner end of said coil passes first from said cannula into said uterus.
17. The method of claim 11 wherein said cannula is slightly curved, said cannula curve is in the sagittal plane of said uterus on insertion, and before said forcing of said strand, said cannula is rotated so that said cannula curve is in the frontal plane of said uterus during said forcing step. i
18. The method 'of claim 11 wherein the transverse sections of said strand and said cannula are oval and the primary plane of said coil is parallel to the lesser dimension of said oval.
19. The contraceptive of claim 1 wherein said follower strand has a lesser diameter than said coil strand.
20. A method of preventing pregnancy comprising insertion within a uterine cavity of a contraceptive comprising an elongated straight strand having tWo free ends and a free shape as a coil in substantially one plane, said strand being readily deformable to a straight line by application of force and always returning to said coil shape when free of said force, said coil and said strand presenting a continuous smooth surface along their longitudinal extents.
21. The method of claim 20 wherein said one plane lies in the frontal plane of said uterus.
22. A method of preventing pregnancy comprising insertion within a uterine cavity of a contraceptive comprising an elongated straight strand having two free ends and a free shape as a coil in substantially one plane adapted to lie within the uterine cavity and a substantially straight follower adapted to extend through the cervical canal, said strand being readily deformable to a straight References Cited by the Examiner UNITED STATES PATENTS 662,716 11/00 Gaedke 128-130X 946,993 1/10 Bolton 58-114 1,881,997 10/32 Browne 267 1 1,896,071 2/33 Clark 128-430 2,085,368 6/37 Kendall 128341 OTHER REFERENCES Product Engineering: Spring Material Substitutes, February 1943, pp. 112113.
Ishihama: Yokahama Medical Bulletin, April 1959, .pp. 89-105, p. 101 relied upon.
vRICHARD A. GAUDET, Primary Examiner.
RICHARD J. HOFFMAN, Examiner.
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3,200,815 August 17, 1965 Lazar Margulies It is hereby certified that error appears in the above numbered patent requiring correction and that the said Letters Patent should read as corrected below.
Column 1, before line 10, insert the following paragraph:
This application is a continuation-in-part app1ication of my copending application Serial No. 68,088,' filed November 8, 1960, now abandoned.
Signed and sealed this 26th day of October 1965.
(SEAL) Altest:
ERNEST W. SWIDER EDWARD J. BRENNER Attesting Officer Commissioner of Patents
Claims (1)
1. AN INTRA-UTERINE CONTRACEPTIVE COMPRISING AN ELONGATED STRAND HAVING TWO FREE ENDS AND A FREE SHAPE IN SUBSTANTIALLY ONE PLANE THAT INCLUDES A COIL ADAPTED TO LIE WITHIN THE UTERINE CAVITY CONNECTED TO A SUBSTANTIALLY STRAIGHT FOLLOWER ADAPTED TO EXTEND THROUGH THE CERVICAL CANAL, SAID STRAND BEING READILY DEFOMRABLE TO A STRAIGHT
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US191674A US3200815A (en) | 1962-04-24 | 1962-04-24 | Coil spring intra-uterine contraceptive device and method of using |
DE19621441359D DE1441359B1 (en) | 1961-10-25 | 1962-06-20 | |
BE619442A BE619442R (en) | 1962-04-24 | 1962-06-27 | Gynecological device |
GB2602062A GB994160A (en) | 1960-11-08 | 1962-07-06 | Intra-uterine contraceptive |
SE7732/62A SE308364B (en) | 1962-04-24 | 1962-07-10 | |
CH831562A CH461703A (en) | 1960-11-08 | 1962-07-10 | Contraceptives |
CY33765A CY337A (en) | 1960-11-08 | 1965-12-29 | Intra-uterine contraceptive |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US191674A US3200815A (en) | 1962-04-24 | 1962-04-24 | Coil spring intra-uterine contraceptive device and method of using |
Publications (1)
Publication Number | Publication Date |
---|---|
US3200815A true US3200815A (en) | 1965-08-17 |
Family
ID=22706456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US191674A Expired - Lifetime US3200815A (en) | 1960-11-08 | 1962-04-24 | Coil spring intra-uterine contraceptive device and method of using |
Country Status (3)
Country | Link |
---|---|
US (1) | US3200815A (en) |
BE (1) | BE619442R (en) |
SE (1) | SE308364B (en) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3250271A (en) * | 1963-04-29 | 1966-05-10 | Lippes Jack | Intrauterine device |
US3256878A (en) * | 1964-05-28 | 1966-06-21 | Schwartz Jerome | Intra-uterine contraceptive appliance |
US3291125A (en) * | 1965-09-23 | 1966-12-13 | Ralph R Robinson | Intrauterine u-shaped pessary |
US3312214A (en) * | 1966-06-06 | 1967-04-04 | Burdick Charles Lalor | Intra-uterine device |
US3319625A (en) * | 1965-08-06 | 1967-05-16 | Appleby Basil Paul | Intra-uterine contraceptive device |
US3323520A (en) * | 1964-10-05 | 1967-06-06 | Herbert H Hall | Intrauterine pessary |
US3374788A (en) * | 1965-06-04 | 1968-03-26 | Deseret Pharmaceutical Company | Contraceptive devices and methods |
US3382869A (en) * | 1966-02-02 | 1968-05-14 | Ortho Pharma Corp | Intrauterine contraceptive device |
US3397690A (en) * | 1965-12-01 | 1968-08-20 | Majzlin Gregory | Intra-uterine contraceptive device |
US3397691A (en) * | 1966-06-02 | 1968-08-20 | Majzlin Gregory | Intra-uterine contraceptive device |
US3405711A (en) * | 1966-07-22 | 1968-10-15 | Maurice I. Bakunin | Intrauterine contraceptive device |
US3410265A (en) * | 1965-12-06 | 1968-11-12 | Marc E Chaft | Intra-uterine contraceptive device and device for inserting the same |
US3442266A (en) * | 1966-02-11 | 1969-05-06 | Vyzk Ustav Pletarsky | Intra-uterine contraceptive device |
US3490446A (en) * | 1966-04-07 | 1970-01-20 | Statni Vyzkumny Ustav Textilni | Contraceptive |
US3509877A (en) * | 1967-08-24 | 1970-05-05 | Leonard S Weiss | Intra-uterine contraceptive device and method of using same |
US3561438A (en) * | 1967-04-04 | 1971-02-09 | Robert Canel | Gynaecological device |
US3810456A (en) * | 1972-04-03 | 1974-05-14 | Medical Concepts Inc | Abortifacient |
US3888975A (en) * | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
US3905360A (en) * | 1971-11-01 | 1975-09-16 | Alza Corp | Intrauterine device for governing the reproductive process |
US3991760A (en) * | 1975-12-02 | 1976-11-16 | The Procter & Gamble Company | Vaginal medicament dispensing means |
US3995633A (en) * | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal Medicament dispensing device |
US4018220A (en) * | 1974-07-19 | 1977-04-19 | Lionel C. R. Emmett | Method of insertion for intrauterine device of C or omega form with tubular inserter |
US4111196A (en) * | 1973-07-27 | 1978-09-05 | Lionel C. R. Emmett | Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement |
US4111190A (en) * | 1976-11-11 | 1978-09-05 | Jane Plumridge | Medical applicator assembly for chain cystourethrographic procedure |
US4194503A (en) * | 1977-11-28 | 1980-03-25 | Csatary Laszlo K | Intra-uterine contraceptive device |
US20130025604A1 (en) * | 2006-12-21 | 2013-01-31 | Oz Harmanli | Vaginal pessary |
WO2019211832A1 (en) * | 2018-04-30 | 2019-11-07 | Ocon Medical Ltd. | Localized delivery of an active agent |
US10905583B2 (en) | 2014-12-11 | 2021-02-02 | Ocon Medical Ltd. | Device positionable in the uterine cavity |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US662716A (en) * | 1900-07-31 | 1900-11-27 | John G L Gaedeke | Intra-uterine battery. |
US946993A (en) * | 1905-02-17 | 1910-01-18 | Siemens Ag | Spring for timepieces. |
US1881997A (en) * | 1930-01-02 | 1932-10-11 | Vere B Browne | Method of making noncorrodible springs |
US1896071A (en) * | 1931-04-24 | 1933-02-07 | George A Clark | Pessary |
US2085368A (en) * | 1935-09-27 | 1937-06-29 | Kendall Charles Marvin | Surgical appliance |
-
1962
- 1962-04-24 US US191674A patent/US3200815A/en not_active Expired - Lifetime
- 1962-06-27 BE BE619442A patent/BE619442R/en active
- 1962-07-10 SE SE7732/62A patent/SE308364B/xx unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US662716A (en) * | 1900-07-31 | 1900-11-27 | John G L Gaedeke | Intra-uterine battery. |
US946993A (en) * | 1905-02-17 | 1910-01-18 | Siemens Ag | Spring for timepieces. |
US1881997A (en) * | 1930-01-02 | 1932-10-11 | Vere B Browne | Method of making noncorrodible springs |
US1896071A (en) * | 1931-04-24 | 1933-02-07 | George A Clark | Pessary |
US2085368A (en) * | 1935-09-27 | 1937-06-29 | Kendall Charles Marvin | Surgical appliance |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3250271A (en) * | 1963-04-29 | 1966-05-10 | Lippes Jack | Intrauterine device |
US3256878A (en) * | 1964-05-28 | 1966-06-21 | Schwartz Jerome | Intra-uterine contraceptive appliance |
US3323520A (en) * | 1964-10-05 | 1967-06-06 | Herbert H Hall | Intrauterine pessary |
US3590816A (en) * | 1965-06-04 | 1971-07-06 | Schmid Inc Julius | Placement unit for intrauterine contraceptive devices |
US3374788A (en) * | 1965-06-04 | 1968-03-26 | Deseret Pharmaceutical Company | Contraceptive devices and methods |
US3319625A (en) * | 1965-08-06 | 1967-05-16 | Appleby Basil Paul | Intra-uterine contraceptive device |
US3291125A (en) * | 1965-09-23 | 1966-12-13 | Ralph R Robinson | Intrauterine u-shaped pessary |
US3397690A (en) * | 1965-12-01 | 1968-08-20 | Majzlin Gregory | Intra-uterine contraceptive device |
US3410265A (en) * | 1965-12-06 | 1968-11-12 | Marc E Chaft | Intra-uterine contraceptive device and device for inserting the same |
US3382869A (en) * | 1966-02-02 | 1968-05-14 | Ortho Pharma Corp | Intrauterine contraceptive device |
US3442266A (en) * | 1966-02-11 | 1969-05-06 | Vyzk Ustav Pletarsky | Intra-uterine contraceptive device |
US3490446A (en) * | 1966-04-07 | 1970-01-20 | Statni Vyzkumny Ustav Textilni | Contraceptive |
US3397691A (en) * | 1966-06-02 | 1968-08-20 | Majzlin Gregory | Intra-uterine contraceptive device |
US3312214A (en) * | 1966-06-06 | 1967-04-04 | Burdick Charles Lalor | Intra-uterine device |
US3405711A (en) * | 1966-07-22 | 1968-10-15 | Maurice I. Bakunin | Intrauterine contraceptive device |
US3561438A (en) * | 1967-04-04 | 1971-02-09 | Robert Canel | Gynaecological device |
US3509877A (en) * | 1967-08-24 | 1970-05-05 | Leonard S Weiss | Intra-uterine contraceptive device and method of using same |
US3905360A (en) * | 1971-11-01 | 1975-09-16 | Alza Corp | Intrauterine device for governing the reproductive process |
US3810456A (en) * | 1972-04-03 | 1974-05-14 | Medical Concepts Inc | Abortifacient |
US3888975A (en) * | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
US4111196A (en) * | 1973-07-27 | 1978-09-05 | Lionel C. R. Emmett | Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement |
US4018220A (en) * | 1974-07-19 | 1977-04-19 | Lionel C. R. Emmett | Method of insertion for intrauterine device of C or omega form with tubular inserter |
US3991760A (en) * | 1975-12-02 | 1976-11-16 | The Procter & Gamble Company | Vaginal medicament dispensing means |
US3995633A (en) * | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal Medicament dispensing device |
US4111190A (en) * | 1976-11-11 | 1978-09-05 | Jane Plumridge | Medical applicator assembly for chain cystourethrographic procedure |
US4194503A (en) * | 1977-11-28 | 1980-03-25 | Csatary Laszlo K | Intra-uterine contraceptive device |
US20130025604A1 (en) * | 2006-12-21 | 2013-01-31 | Oz Harmanli | Vaginal pessary |
US10507094B2 (en) * | 2006-12-21 | 2019-12-17 | Oz Harmanli | Vaginal pessary |
US10905583B2 (en) | 2014-12-11 | 2021-02-02 | Ocon Medical Ltd. | Device positionable in the uterine cavity |
WO2019211832A1 (en) * | 2018-04-30 | 2019-11-07 | Ocon Medical Ltd. | Localized delivery of an active agent |
Also Published As
Publication number | Publication date |
---|---|
BE619442R (en) | 1962-12-27 |
SE308364B (en) | 1969-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3200815A (en) | Coil spring intra-uterine contraceptive device and method of using | |
US11850181B2 (en) | Intrauterine contraceptive device | |
US3374788A (en) | Contraceptive devices and methods | |
US3881475A (en) | Intra-uterine contraceptive device | |
US4595000A (en) | Tubular pessary as a contraceptive means | |
US3312215A (en) | Uterocervical cannula | |
US3973560A (en) | Intrauterine device of C or omega form | |
US2122579A (en) | Intra-uterine device | |
CA1154642A (en) | Sound for retrieval of retracted threads to intrauterine contraceptive devices | |
US10166141B2 (en) | Intrauterine contraceptive device | |
US4111196A (en) | Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement | |
JP2018504950A (en) | Instruments that can be placed in the uterine cavity | |
US3559641A (en) | Intrauterine device | |
US10335312B2 (en) | Vaginal ring removal device and methods | |
US3675648A (en) | Intrauterine contraceptive device | |
US3291125A (en) | Intrauterine u-shaped pessary | |
US3306286A (en) | Intrauterine device | |
US4018220A (en) | Method of insertion for intrauterine device of C or omega form with tubular inserter | |
US3397691A (en) | Intra-uterine contraceptive device | |
EP0556908A1 (en) | Intrauterine and/or intravaginal device | |
IE57545B1 (en) | Assembly of intra-uterine contraceptive device and inserter | |
US3353533A (en) | Intra-uterine contraceptive appliance | |
US3511231A (en) | Intrauterine device for postpartum patient | |
US3675647A (en) | Intrauterine contraceptive device | |
CN204411072U (en) | A kind of recoverability umbrella common oviduct IUD |